The Cost of Movement

The clinical decision to move a patient is often made in minutes. The financial authorization can take hours. The patient lives in the gap between those clocks.
Moving a patient to care is not free, and the cost is not incidental to the clinical decision – it is often the thing that determines whether the clinical decision can be acted on at all. In much of the region, the question “can we move this patient?” collapses, within minutes, into the question “who is paying, and can they confirm it right now?” – and the second question has stalled more transfers than weather ever has.
The costs come in tiers, and the gaps between tiers are large.
Commercial transport – a stretcher booking or medical escort on a scheduled flight – is the cheapest option where it is clinically appropriate and operationally available. But it is constrained by airline schedules, aircraft configuration and the patient’s stability, and it is rarely an emergency tool.
A transfer is not a flight. It is an episode.
Charter raises both the capability and the price, buying schedule control and sometimes range that commercial cannot offer.
Dedicated air ambulance / medevac sits at the top: a flying intensive-care environment with clinical crew, available when the patient’s condition demands continuous care in transit or when nothing else can fly the route in time. It is also the most expensive by a wide margin, frequently reaching well into five figures for a single regional movement.
But the headline transport price understates the true cost of movement, which includes a tail of less visible expenses: receiving-facility charges, the cost of the patient’s stay and treatment at the destination, accompanying family travel and accommodation, repatriation once stable, and the opportunity cost of the time lost while all of it is arranged. A transfer is not a flight. It is an episode, and the flight is only its most dramatic line item.

This is where cost stops being a finance issue and becomes a clinical one. Every hour spent establishing who pays is an hour the patient is not moving. The most consequential delays in regional transfer are frequently not clinical or logistical at all – they are financial authorization delays, the time it takes to find the person who can guarantee payment and get that guarantee into the hands of a transport provider or receiving center that will not move without it. In a time-critical case, that administrative gap is indistinguishable, in its effect on the patient, from a lack of capability.
Every hour spent establishing who pays is an hour the patient is not moving.
The structural problem is that cost decisions and clinical decisions are made by different people on different clocks. The clinician decides in minutes that a patient must move. The financial authorization may take hours, routed through people who are not at the bedside, may not be reachable after hours, and are managing risk rather than a dying patient. The two clocks are not synchronized, and the patient lives in the gap between them.
The solutions are not mysterious, and they are mostly about doing the financial work before the crisis rather than during it: pre-agreed payment mechanisms for transfers, standing authorization for defined emergency categories, clarity about who guarantees payment and how to reach them at any hour, and financial documentation prepared in advance rather than assembled under pressure. None of this reduces the underlying cost of moving a patient. What it does is remove cost as a cause of delay – separating the question of who ultimately pays from the question of whether the patient can move now. Those two questions should never share a clock.
As long as the money decision and the clinical decision run on different clocks, cost will keep killing patients who were never out of clinical reach.
We take up the harder, system-level version of this – who should pay, and how the region might share the burden of movement – in Section V. Here the point is narrower and more urgent: as long as the money decision and the clinical decision run on different clocks, cost will keep killing patients who were never out of clinical reach. It will simply do it quietly, in the form of delay.
RESEARCH LENS
Risk-stratify both payment and transport
In a Tokyo cohort of uninsured non-resident patients, the absence of third-party financial support – mainly travel insurance – was the strongest independent predictor of unpaid hospital charges. A small U.S. health-system review found no adverse outcomes among 27 stable patients transferred by non-ambulance vehicle, but the sample is far too small to generalize. The operational lesson is to distinguish clinical transport need from administrative default while securing payment before avoidable delay begins.
Sources: Saeki et al. (2025); Day, Breighner & Flamm (2025).